Dan Everitt joins CHASE as a Senior MedTech Recruitment Consultant

CHASE welcomes Dan as Senior Recruitment Consultant in MedTech, bringing 18+ years' UK pharma experience to boost talent and support division growth in 2024.

August 28, 2024
Dan Everitt

CHASE welcomes Dan as a Senior Recruitment Consultant to our MedTech team. He'll be working alongside Jennie Wickins, Nick Johnson, and Leonie Jackman-Jones to drive the continued growth of our MedTech division. Dan brings over 18 years of experience in MedTech and Pharmaceutical recruitment in the UK. He began his Pharma career in 2005, and he's previously collaborated with several CHASE team members, including Graham Hawthorn, Danny Walsh, Amanda McIntyre, Nick Johnson, and Helen Weller.

Dan's deep understanding of the MedTech industry and his ability to identify top talent through various channels will be invaluable in delivering exceptional results for both clients and candidates.

Huw Nicholas, Recruitment Director at CHASE, said: “We're thrilled to have Dan join our MedTech team. His industry experience and knowledge will be instrumental in securing the best talent for our clients. Welcome, Dan!"

This post was originally published in 2024.

FAQs

Browse other insights

Explore our latest thinking, event updates and industry insights to stay informed.

All resources

NHS neighbourhood health: lessons from Kent and Medway

News
September 29, 2026

Kent and Medway has signed the first local variation of the PCN DES, worth £10 million a year. CHASE assesses what the framework still leaves unsettled.

Read story

NHS Carbon Reduction Plan 2027: a harder test for suppliers

News
September 17, 2026

From April 2027, NHS Carbon Reduction Plan rules demand full scope 3 emissions data. CHASE assesses what this means for pharma and medtech suppliers.

Read story

Yvette Cooper as health secretary: what the reshuffle means for pharma, medtech and the NHS

News
August 25, 2026

Yvette Cooper is the UK's new health secretary after a reshuffle that also reshaped the medtech brief. Here's what it means for pharma, medtech and NHS teams.

Read story